News

President Donald Trump says pharma tariffs could go as high as 250%. UBS downgrades Novo Nordisk stock to neutral and lowers ...
US market rise on Palantir’s strong earnings while Trump’s tariff threats and mixed corporate results weigh on broader market ...
Mantle (MNT) has surged by more than 20% as traders reacted to a combination of strong liquidity inflows, growing user ...
BIT Mining launches its first self-operated Solana validator and acquires $4.89M in SOL, advancing its $300M strategy to ...
Ripple has met its legal obligations in the SEC case, including a $125M fine. Final closure now depends on the SEC’s next ...
Pfizer stock rises after a strong Q2, boosted by cost savings, pipeline progress, and an upgraded 2025 profit outlook.
The Palantir stock price continued soaring after it published strong financial results. Here's why the PLTR share price may ...
Tesla’s sales in the UK and Germany plunged in July, as Chinese EV maker BYD posted sharp growth, intensifying competition in ...
Coinbase announces $2B convertible note offering for institutional buyers, potentially funding Bitcoin purchases and ...
CEO Alex Karp reveals how fast Palantir will grow over the next five years. His forecast may justify PLTR shares valuation.
Dow Futures inch higher as earnings from Palantir, AMD, Disney & more set the tone; oil, tariffs, and tech in focus.
Gold’s blockbuster rally in the first quarter of this year seems to have dissipated, and gains are expected to be limited in ...